Balloon battle: could a Drug-Coated balloon replace stents in tiny heart vessels?
NCT ID NCT07397845
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for narrowed small heart arteries: paclitaxel-coated balloons versus drug-eluting stents. About 1,380 people with stable or unstable chest pain will be randomly assigned to one of two balloon types or a standard stent. The goal is to see if balloons work as well as stents at preventing heart-related death, heart attacks, or the need for repeat procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
paclitaxel-coated balloon catheter
What this could lead to
If successful, this could offer a stent-free option for treating small, complex heart arteries, potentially reducing long-term complications.
What could go wrong
This is an early-stage trial without a phase designation, so results are uncertain. Balloons may not keep arteries open as well as stents, and there is a risk of vessel closure or heart attack.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Luzerner Kantonsspital Spitalstrasse, 6000 Luzern 16, Switzerland
RECRUITINGLucerne, Canton of Lucerne, 6000 Luzern 16, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••